A critical discovery in cancer study is emerging with the use of nanobodies to reactivate mutated p53. This crucial tumor suppressor protein is frequently disabled in various forms of tumors, resulting uncontrolled https://1001bookmarks.com/story21796226/mini-antibodies-revive-p53-the-new-approach-for-cancer-management